Use this button to switch between dark and light mode.

FDA Administrative Decision Challenges

January 17, 2023

Obtain guidance on challenging adverse Food and Drug Administration (FDA) administrative decisions. This practice note includes strategies for obtaining a final agency decision that can be challenged in court, overcoming agency deference challenges, and selecting a jurisdiction.

Read now »


Related Content

  • FDA Complete Response Letters
    Be prepared to respond to an FDA-issued complete response letter (CRL). A CRL is a material, reportable event for public companies, and potentially devastating for nonpublic companies that have staked their reputation on the FDA’s approval or licensing of a particular drug product.
  • FDA Warning Letters Tracker
    Monitor warning letters issued by the FDA in response to FDA’s determination that a manufacturer has violated, or potentially violated, applicable requirements of the Food, Drug, and Cosmetics Act (FDCA), FDA regulations, or agency guidance. 

Practical Guidance Updates
Featuring the latest updates from your Practical Guidance account.


Experience results today with practical guidance, legal research, and data-driven insights—all in one place.

Experience Lexis+